Novavax
NVAX
#5597
Rank
HK$10.35 B
Marketcap
HK$62.99
Share price
1.45%
Change (1 day)
26.79%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): HK$3.62 Billion

According to Novavax's latest financial reports the company's current earnings are HK$1.08 Billion. , an increase over its 2024 earnings that were of -HK$1.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 HK$3.64 B-396.87%
2024 -HK$1.23 Billion-70.39%
2023 -HK$4.15 Billion-16.59%
2022 -HK$4.97 Billion-62.58%
2021 -HK$13.27 Billion320.54%
2020 -HK$3.16 Billion234.22%
2019 -HK$0.95 Billion-30.17%
2018 -HK$1.36 Billion1.69%
2017 -HK$1.33 Billion-36.44%
2016 -HK$2.1 Billion70.4%
2015 -HK$1.23 Billion89.27%
2014 -HK$0.65 Billion59.83%
2013 -HK$0.41 Billion81.9%
2012 -HK$0.23 Billion50.33%
2011 -HK$0.15 Billion
2009 -HK$0.3 Billion8.8%
2008 -HK$0.27 Billion18.01%
2007 -HK$0.23 Billion18.33%
2006 -HK$0.2 Billion168.31%
2005 -HK$71.85 Million-62.51%
2004 -HK$0.2 Billion52.4%
2003 -HK$0.13 Billion-28.21%
2002 -HK$0.18 Billion
2000 -HK$99.83 Million177%
1999 -HK$36.04 Million-11.54%
1998 -HK$40.74 Million10.64%
1997 -HK$36.83 Million-9.62%
1996 -HK$40.74 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
HK$128.10 B 3,418.72%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$79.84 B 2,093.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$110.52 B 2,935.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$77.52 B 2,029.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-HK$5.51 Billion-251.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$2.26 Billion-161.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$0.16 B-95.55%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-HK$63.66 Million-101.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
HK$2.09 B-42.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$1.29 B-64.43%๐Ÿ‡บ๐Ÿ‡ธ USA